NO874904D0 - Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser. - Google Patents

Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser.

Info

Publication number
NO874904D0
NO874904D0 NO874904A NO874904A NO874904D0 NO 874904 D0 NO874904 D0 NO 874904D0 NO 874904 A NO874904 A NO 874904A NO 874904 A NO874904 A NO 874904A NO 874904 D0 NO874904 D0 NO 874904D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
imidazopyridine compounds
new imidazopyridine
new
Prior art date
Application number
NO874904A
Other languages
English (en)
Other versions
NO874904L (no
Inventor
Youichi Shiokawa
Masanobu Nagano
Hiromichi Itani
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628262A external-priority patent/GB8628262D0/en
Priority claimed from GB878723439A external-priority patent/GB8723439D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO874904D0 publication Critical patent/NO874904D0/no
Publication of NO874904L publication Critical patent/NO874904L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO874904A 1986-11-26 1987-11-25 Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser. NO874904L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868628262A GB8628262D0 (en) 1986-11-26 1986-11-26 Imidazopyridine compounds
GB878723439A GB8723439D0 (en) 1987-10-06 1987-10-06 Imidazopyridine compounds

Publications (2)

Publication Number Publication Date
NO874904D0 true NO874904D0 (no) 1987-11-25
NO874904L NO874904L (no) 1988-05-27

Family

ID=26291587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874904A NO874904L (no) 1986-11-26 1987-11-25 Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser.

Country Status (13)

Country Link
US (1) US4831041A (no)
EP (1) EP0268989B1 (no)
KR (1) KR880006237A (no)
CN (1) CN87108027A (no)
AU (1) AU8169387A (no)
DE (1) DE3780263T2 (no)
DK (1) DK608887A (no)
ES (1) ES2064310T3 (no)
FI (1) FI875157A (no)
GR (1) GR3005685T3 (no)
HU (1) HUT45526A (no)
IL (1) IL84522A0 (no)
NO (1) NO874904L (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
DE3855692D1 (de) * 1987-07-16 1997-01-16 Byk Gulden Lomberg Chem Fab Imidazo[1,2-a]pyridine
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
DE69108138T2 (de) * 1990-07-30 1995-07-06 Takeda Chemical Industries Ltd Imidazopyridinderivate und ihre Verwendung.
MY110439A (en) * 1991-02-07 1998-05-30 Ishihara Sangyo Kaisha N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
GB9201693D0 (en) * 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
NZ290818A (en) * 1994-07-28 1998-10-28 Byk Gulden Lomberg Chem Fab Benzyl-imidazopyridines
CA2196075A1 (en) * 1994-07-28 1996-02-08 Gerhard Grundler Halogenated imidazopyridines
WO1996003405A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridin-azolidinone
ATE294802T1 (de) * 1996-01-26 2005-05-15 Altana Pharma Ag 3-alkylimidazopyridine
AU1545297A (en) * 1996-01-26 1997-08-20 Byk Gulden Imidazopyridine halides
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
EP2797597B1 (en) 2011-12-28 2020-02-26 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
ES2643403T3 (es) 2011-12-28 2017-11-22 Global Blood Therapeutics, Inc. Compuestos de benzaldehído sustituidos y métodos para su uso en el aumento de la oxigenación tisular
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR102293060B1 (ko) 2013-03-15 2021-08-23 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
KR20150132146A (ko) 2013-03-15 2015-11-25 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EP2970196B1 (en) 2013-03-15 2020-11-25 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
CN114213390A (zh) 2014-02-07 2022-03-22 全球血液疗法股份有限公司 一种化合物的结晶多晶型物
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
TWI825524B (zh) 2016-05-12 2023-12-11 美商全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
CN87108027A (zh) 1988-06-08
IL84522A0 (en) 1988-04-29
KR880006237A (ko) 1988-07-22
DK608887A (da) 1988-05-27
ES2064310T3 (es) 1995-02-01
EP0268989A1 (en) 1988-06-01
DE3780263T2 (de) 1992-12-24
DE3780263D1 (de) 1992-08-13
DK608887D0 (da) 1987-11-19
FI875157A (fi) 1988-05-27
US4831041A (en) 1989-05-16
EP0268989B1 (en) 1992-07-08
GR3005685T3 (no) 1993-06-07
NO874904L (no) 1988-05-27
FI875157A0 (fi) 1987-11-23
AU8169387A (en) 1988-06-02
HUT45526A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
NO874904D0 (no) Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser.
NO873091D0 (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO167392C (no) Fremgangsmaate for fremstilling av imidazopyridiner.
NO167282C (no) Analogifremgangsmaate for fremstilling av nye 8-substituerte 2-aminotetraliner.
NO871727D0 (no) Fremgangsmaate for fremstilling av nye kinolinderivater.
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO852565L (no) Fremgangsmaate for fremstilling av nye funksjonelle gangliosid-derivater.
NO874467D0 (no) Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
NO904059D0 (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO892543D0 (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
NO901813D0 (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO862230L (no) Fremgangsmaate for fremstilling av nye kinolinderivater.
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO872393L (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO904069L (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO873400L (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO168941C (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO860538L (no) Fremgangsmaate ved fremstilling av nye antiallergisk virksomme substanser.
NO880345L (no) Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
NO874698D0 (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.
NO884901L (no) Fremgangsmaate for fremstilling av nye indenofuran-derivater.
NO873019D0 (no) Fremgangsmaate for fremstilling av tetrahydrobenzotiazolkinolin-derivater.